James Marriott

Dr Marriott attended medical school at Queen’s University and completed his neurology residency at the University of Ottawa in 2007. He completed a three-year Multiple Sclerosis Clinical Fellow at St. Michael’s Hospital, Toronto in 2010 and a Master’s of Science degree through the University of Toronto in 2011. He joined the University of Toronto in 2022 after 12 years at the University of Manitoba.

His research includes two broad components aimed at evaluating multiple sclerosis (MS) therapies. The first is a through participation in clinical trials; including investigator-initiated trials of symptomatic therapies to better treat complications of MS and also larger national/international projects to develop new treatments to prevent worsening disability in MS.

Complementing this participation in MS clinical trials, Dr Marriott is interested in studying the real-world impact of medications for MS using administrative databases to better characterize treatment effectiveness at the level of both the individual person with MS as well as at the population level.